This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Kalydeco
  • /
  • A Study to Evaluate the Safety of Long-term Ivacaf...
Clinical trial

A Study to Evaluate the Safety of Long-term Ivacaftor Treatment in Subjects With Cystic Fibrosis Who Are Less Than 24 Months of Age at Treatment Initiation and Have an Approved Ivacaftor-Responsive Mutation

Read time: 3 mins
Last updated:16th Aug 2017
Identifier: NCT03277196
Register free for full access to medthority.com